Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200061727Phase 4Not yet recruiting
Phase 4, open-label trial of ciprofol, propofol and alfentanil in None (4 arms), sponsored by Second Affiliated Hospital of Hainan Medical University. Primary endpoints: mean arterial pressure, oxygen saturation and 2 more. Planned start Jul 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200061727.